Costello Medical Consulting (United Kingdom)

Recent papers from Costello Medical Consulting (United Kingdom)

1. Methodological considerations for indirect treatment comparisons of HIV incidence for long-acting injectable pre-exposure prophylaxisJournal of Comparative Effectiveness Research · 2026
2. Insulin Efsitora Demonstrates Similar Efficacy and Safety Profiles to Insulin Icodec in Insulin‐Experienced Individuals With Type 2 Diabetes Mellitus: Matching‐Adjusted Indirect Comparisons of QWINT ‐3 Versus ONWARDS 2, and QWINT ‐4 Versus ONWARDS 4Diabetes Obesity and Metabolism · 2026
3. The impact of anhedonia on physical health and somatic diseases: an exploratory literature reviewEuropean Neuropsychopharmacology · 2026
4. Hepatocellular carcinoma risk reduction associated with antiviral treatment in patients with noncirrhotic chronic hepatitis B: a systematic literature review and comparative meta-analysisBMC Gastroenterology · 2026
5. Minimally acceptable criteria and required sample size for an accuracy study of non-invasive prenatal testing of sickle cell disease in screen positive women in England: results of a decision tree modelDiagnostic and Prognostic Research · 2026
6. Modelling the cost-effectiveness of non-invasive prenatal testing in the English sickle cell and thalassaemia screening pathwayDiagnostic and Prognostic Research · 2026
7. Public health interventions to improve the mental health and mental health literacy of young people in resource-limited settings: a systematic reviewFrontiers in Public Health · 2026
8. Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysisJournal of Comparative Effectiveness Research · 2026
9. Health-related quality of life in COVID-19 in the United Kingdom: a vignette studyHealth Economics Review · 2026
10. Systematic review of economic evaluations in thalassaemia screening programmes globally: developing guidance for low- and middle-income (LMIC) settingsBMJ Open · 2026
11. Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.2026
12. Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission – a UK case studyJournal of Medical Economics · 2026
13. Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trialJournal of Medical Economics · 2026
14. Burden of Dengue in Pregnant Individuals: A Systematic Literature ReviewAmerican Journal of Tropical Medicine and Hygiene · 2026
15. Network meta-analysis: relative clinical efficacy and safety of elafibranor versus seladelpar as second-line treatment for patients with primary biliary cholangitisJournal of Comparative Effectiveness Research · 2026
16. Cost comparison of osimertinib plus platinum-pemetrexed versus amivantamab plus lazertinib for the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancerJournal of Medical Economics · 2026
17. Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature ReviewAdvances in Therapy · 2026
18. Evaluating the patterns of use and safety of lenalidomide treatment in myelodysplastic syndromes: a European, observational multi-registry studyTherapeutic Advances in Drug Safety · 2026
19. DETECT-VTE: an audit of patients with venous thromboembolism and their characteristics in general practice in the United KingdomResearch and Practice in Thrombosis and Haemostasis · 2026
20. P0675IBD-GAPS: Inflammatory Bowel Disease Guidelines Alignment in Clinical Practice SurveyJournal of Crohn s and Colitis · 2026